GLOBUS MEDICAL, INC. (GMED) Shareholders’ equity 2016–2025
GLOBUS MEDICAL, INC. (GMED) shareholders’ equity at each fiscal year-end, per SEC filings.
$4.6BFY2025 · since FY2016: $832.1M → $4.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.6B | +9.5% |
| FY2024 | $4.2B | +4.5% |
| FY2023 | $4.0B | +116.5% |
| FY2022 | $1.8B | +6.0% |
| FY2021 | $1.7B | +15.6% |
| FY2020 | $1.5B | +7.4% |
| FY2019 | $1.4B | +18.3% |
| FY2018 | $1.2B | +22.5% |
| FY2017 | $967.8M | +16.3% |
| FY2016 | $832.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice